COVID and Lyme disease survey: Discussion with Drs. Daniel Cameron and Richard Horowitz

Dr. Cameron and Dr. Horowitz discuss the initial findings from a COVID-19 and Lyme disease survey examining the risks of COVID and/or the vaccine for Lyme disease patients.

Dr. Horowitz also shares his thoughts and insights on the Omicron Variant and how COVID and the variant may impact and overstimulate the immune system. He describes potential etiologies for post-COVID long hauler syndrome and offers several possible treatments to minimize the side effects.